ACET
Adicet Bio, Inc.$7.62+0.61 (+8.71%)Prev Close$7.00·MCap$73.1M·P/E—·Vol161.0K·Yield—
▲
Buys (12M)
1
$1.60M
▼
Sells (12M)
4
$698.8K
◆
Net Activity
Net Buyer
$905.1K
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Adicet Bio, Inc. (ACET) has been dominated by buying, with 1 insider purchase totaling $1.60M and 4 insider sales totaling $698.8K. The most recent insider transaction was by RA CAPITAL MANAGEMENT, L.P. (10 percent owner), who purchased $1.60M worth of shares on Apr 13, 2026. Adicet Bio, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $73.1M.
ACET Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Buy | 223,596 | $7.17 | $1.60M2.3% OS | 1,182,624 |
| Apr 9, 2026 | ORBIMED ADVISORS LLC | 10 percent owner | Sell | 104,658 | $6.45 | $674.8K1.1% OS | 34,923-75% |
| Jan 24, 2026 | Aftab Blake | Chief Scientific Officer | Sell | 535 | $8.44 | $4.5K | 0 |
| Jan 24, 2026 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 546 | $8.44 | $4.6K | 0 |
| Jan 24, 2026 | Schor Chen | President & CEO | Sell | 1,755 | $8.44 | $14.8K | 0 |
| Jan 24, 2025 | Aftab Blake | Chief Scientific Officer | Sell | 6,270 | $0.92 | $5.8K | 0 |
| Jan 24, 2025 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 8,752 | $0.92 | $8.1K | 0 |
| Jan 24, 2025 | Healey Don | Chief Technology Officer | Sell | 8,560 | $0.92 | $7.9K | 0 |
| Jan 24, 2025 | Schor Chen | President & CEO | Sell | 28,101 | $0.92 | $25.9K | 0 |
| Jun 5, 2024 | Kauffman Michael | Director | Sell | 5,900 | $1.43 | $8.4K | 0 |
| Jan 25, 2024 | GORDON CARL L | Director | Buy | 3,125,000 | $2.40 | $7.50M32.6% OS | 0 |
| Jan 24, 2024 | Aftab Blake | Chief Scientific Officer | Sell | 3,565 | $2.40 | $8.6K | 0 |
| Jan 24, 2024 | Galimi Francesco | SVP & Chief Medical Officer | Sell | 4,957 | $2.40 | $11.9K | 0 |
| Jan 24, 2024 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 4,320 | $2.40 | $10.4K | 0 |
| Jan 24, 2024 | Healey Don | Chief Technology Officer | Sell | 4,870 | $2.40 | $11.7K | 0 |
| Jan 24, 2024 | Schor Chen | President & CEO | Sell | 15,290 | $2.40 | $36.7K | 0 |
| Oct 12, 2023 | Aftab Blake | Chief Scientific Officer | Sell | 7,933 | $1.35 | $10.7K | 0 |
| Oct 2, 2023 | Galimi Francesco | SVP & Chief Medical Officer | Sell | 8,093 | $1.37 | $11.1K | 0 |
| Oct 2, 2023 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 7,096 | $1.37 | $9.7K | 0 |
| Oct 2, 2023 | Healey Don | Chief Technology Officer | Sell | 9,069 | $1.37 | $12.4K | 0 |
| Sep 28, 2023 | Schor Chen | President & CEO | Buy | 11,000 | $1.38 | $15.1K | 0 |
| Sep 28, 2023 | Schor Chen | President & CEO | Sell | 34,208 | $1.38 | $47.1K | 0 |
| Jun 30, 2023 | DUBIN STEVE | Director | Buy | 5,000 | $2.40 | $12.0K | 0 |
| Jun 27, 2023 | GORDON CARL L | Director | Buy | 875,000 | $2.09 | $1.83M9.1% OS | 0 |
| Feb 15, 2023 | Healey Don | Chief Technology Officer | Sell | 4,533 | $7.57 | $34.3K | 0 |
| Feb 10, 2023 | Healey Don | Chief Technology Officer | Sell | 10,467 | $7.98 | $83.5K | 0 |
| Nov 10, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 6,967 | $21.00 | $146.3K | 0 |
| Nov 10, 2022 | Schor Chen | President & CEO | Sell | 39,955 | $20.30 | $811.2K | 0 |
| Nov 7, 2022 | Schor Chen | President & CEO | Sell | 30,000 | $19.05 | $571.5K | 0 |
| Nov 2, 2022 | Schor Chen | President & CEO | Sell | 25,313 | $18.04 | $456.7K | 0 |
| Oct 19, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 8,067 | $16.27 | $131.3K | 0 |
| Oct 12, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 9,579 | $15.83 | $151.6K | 0 |
| Oct 4, 2022 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 7,096 | $14.22 | $100.9K | 0 |
| Oct 4, 2022 | Healey Don | Chief Technology Officer | Sell | 7,933 | $14.22 | $112.8K | 0 |
| Oct 4, 2022 | Schor Chen | President & CEO | Sell | 21,288 | $14.22 | $302.7K | 0 |
| Sep 14, 2022 | Schor Chen | President & CEO | Sell | 952 | $18.00 | $17.1K | 0 |
| Sep 9, 2022 | Schor Chen | President & CEO | Sell | 78,412 | $16.80 | $1.32M0.8% OS | 0 |
| Aug 4, 2022 | Galimi Francesco | SVP & Chief Medical Officer | Sell | 5,533 | $18.25 | $101.0K | 0 |
| Aug 4, 2022 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 4,696 | $18.25 | $85.7K | 0 |
| Aug 4, 2022 | Schor Chen | President & CEO | Sell | 21,288 | $18.25 | $388.5K | 0 |
| Aug 3, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 6,968 | $18.00 | $125.4K | 0 |
| Aug 1, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 6,968 | $16.64 | $115.9K | 0 |
| Jul 5, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 1,363 | $14.50 | $19.8K | 0 |
| Apr 1, 2022 | Galimi Francesco | SVP & Chief Medical Officer | Sell | 15,600 | $21.00 | $327.6K | 0 |
| Mar 9, 2022 | Jakobovits Aya | Director | Sell | 2,000 | $14.00 | $28.0K | 0 |
| Feb 16, 2022 | Jakobovits Aya | Director | Sell | 2,000 | $14.83 | $29.7K | 0 |
| Feb 14, 2022 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 4,696 | $14.27 | $67.0K | 0 |
| Feb 14, 2022 | Healey Don | Chief Technology Officer | Sell | 5,533 | $14.27 | $79.0K | 0 |
| Feb 14, 2022 | Schor Chen | President & CEO | Sell | 21,288 | $14.27 | $303.8K | 0 |
| Jan 28, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 5,564 | $11.69 | $65.0K | 0 |
Showing 1–50 of 66
1 / 2
ACET Insider Buying Activity
The following table shows recent insider purchases of Adicet Bio, Inc. (ACET) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Buy | 223,596 | $7.17 | $1.60M2.3% OS | 1,182,624 |
| Jan 25, 2024 | GORDON CARL L | Director | Buy | 3,125,000 | $2.40 | $7.50M32.6% OS | 0 |
| Sep 28, 2023 | Schor Chen | President & CEO | Buy | 11,000 | $1.38 | $15.1K | 0 |
| Jun 30, 2023 | DUBIN STEVE | Director | Buy | 5,000 | $2.40 | $12.0K | 0 |
| Jun 27, 2023 | GORDON CARL L | Director | Buy | 875,000 | $2.09 | $1.83M9.1% OS | 0 |
ACET Insider Selling Activity
The following table shows recent insider sales of Adicet Bio, Inc. (ACET) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | ORBIMED ADVISORS LLC | 10 percent owner | Sell | 104,658 | $6.45 | $674.8K1.1% OS | 34,923-75% |
| Jan 24, 2026 | Aftab Blake | Chief Scientific Officer | Sell | 535 | $8.44 | $4.5K | 0 |
| Jan 24, 2026 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 546 | $8.44 | $4.6K | 0 |
| Jan 24, 2026 | Schor Chen | President & CEO | Sell | 1,755 | $8.44 | $14.8K | 0 |
| Jan 24, 2025 | Aftab Blake | Chief Scientific Officer | Sell | 6,270 | $0.92 | $5.8K | 0 |
| Jan 24, 2025 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 8,752 | $0.92 | $8.1K | 0 |
| Jan 24, 2025 | Healey Don | Chief Technology Officer | Sell | 8,560 | $0.92 | $7.9K | 0 |
| Jan 24, 2025 | Schor Chen | President & CEO | Sell | 28,101 | $0.92 | $25.9K | 0 |
| Jun 5, 2024 | Kauffman Michael | Director | Sell | 5,900 | $1.43 | $8.4K | 0 |
| Jan 24, 2024 | Aftab Blake | Chief Scientific Officer | Sell | 3,565 | $2.40 | $8.6K | 0 |
| Jan 24, 2024 | Galimi Francesco | SVP & Chief Medical Officer | Sell | 4,957 | $2.40 | $11.9K | 0 |
| Jan 24, 2024 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 4,320 | $2.40 | $10.4K | 0 |
| Jan 24, 2024 | Healey Don | Chief Technology Officer | Sell | 4,870 | $2.40 | $11.7K | 0 |
| Jan 24, 2024 | Schor Chen | President & CEO | Sell | 15,290 | $2.40 | $36.7K | 0 |
| Oct 12, 2023 | Aftab Blake | Chief Scientific Officer | Sell | 7,933 | $1.35 | $10.7K | 0 |
| Oct 2, 2023 | Galimi Francesco | SVP & Chief Medical Officer | Sell | 8,093 | $1.37 | $11.1K | 0 |
| Oct 2, 2023 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 7,096 | $1.37 | $9.7K | 0 |
| Oct 2, 2023 | Healey Don | Chief Technology Officer | Sell | 9,069 | $1.37 | $12.4K | 0 |
| Sep 28, 2023 | Schor Chen | President & CEO | Sell | 34,208 | $1.38 | $47.1K | 0 |
| Feb 15, 2023 | Healey Don | Chief Technology Officer | Sell | 4,533 | $7.57 | $34.3K | 0 |
| Feb 10, 2023 | Healey Don | Chief Technology Officer | Sell | 10,467 | $7.98 | $83.5K | 0 |
| Nov 10, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 6,967 | $21.00 | $146.3K | 0 |
| Nov 10, 2022 | Schor Chen | President & CEO | Sell | 39,955 | $20.30 | $811.2K | 0 |
| Nov 7, 2022 | Schor Chen | President & CEO | Sell | 30,000 | $19.05 | $571.5K | 0 |
| Nov 2, 2022 | Schor Chen | President & CEO | Sell | 25,313 | $18.04 | $456.7K | 0 |
| Oct 19, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 8,067 | $16.27 | $131.3K | 0 |
| Oct 12, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 9,579 | $15.83 | $151.6K | 0 |
| Oct 4, 2022 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 7,096 | $14.22 | $100.9K | 0 |
| Oct 4, 2022 | Healey Don | Chief Technology Officer | Sell | 7,933 | $14.22 | $112.8K | 0 |
| Oct 4, 2022 | Schor Chen | President & CEO | Sell | 21,288 | $14.22 | $302.7K | 0 |
| Sep 14, 2022 | Schor Chen | President & CEO | Sell | 952 | $18.00 | $17.1K | 0 |
| Sep 9, 2022 | Schor Chen | President & CEO | Sell | 78,412 | $16.80 | $1.32M0.8% OS | 0 |
| Aug 4, 2022 | Galimi Francesco | SVP & Chief Medical Officer | Sell | 5,533 | $18.25 | $101.0K | 0 |
| Aug 4, 2022 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 4,696 | $18.25 | $85.7K | 0 |
| Aug 4, 2022 | Schor Chen | President & CEO | Sell | 21,288 | $18.25 | $388.5K | 0 |
| Aug 3, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 6,968 | $18.00 | $125.4K | 0 |
| Aug 1, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 6,968 | $16.64 | $115.9K | 0 |
| Jul 5, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 1,363 | $14.50 | $19.8K | 0 |
| Apr 1, 2022 | Galimi Francesco | SVP & Chief Medical Officer | Sell | 15,600 | $21.00 | $327.6K | 0 |
| Mar 9, 2022 | Jakobovits Aya | Director | Sell | 2,000 | $14.00 | $28.0K | 0 |
| Feb 16, 2022 | Jakobovits Aya | Director | Sell | 2,000 | $14.83 | $29.7K | 0 |
| Feb 14, 2022 | Harvey Brian Nicholas | Chief Financial Officer | Sell | 4,696 | $14.27 | $67.0K | 0 |
| Feb 14, 2022 | Healey Don | Chief Technology Officer | Sell | 5,533 | $14.27 | $79.0K | 0 |
| Feb 14, 2022 | Schor Chen | President & CEO | Sell | 21,288 | $14.27 | $303.8K | 0 |
| Jan 28, 2022 | Aftab Blake | Chief Scientific Officer | Sell | 5,564 | $11.69 | $65.0K | 0 |
ACET Insiders
Similar Stocks to ACET
VRTX
Vertex Pharmaceuticals Incorporated
$438.44-1.32%
$110.83B
REGN
Regeneron Pharmaceuticals, Inc.
$746.35-1.17%
$77.81B
ALNY
Alnylam Pharmaceuticals, Inc.
$334.23-1.53%
$42.72B
INSM
Insmed Incorporated
$149.99-2.53%
$33.37B
RVMD
Revolution Medicines, Inc.
$150.40+2.02%
$27.01B
UTHR
United Therapeutics Corporation
$583.94+1.03%
$25.32B
RPRX
Royalty Pharma plc
$48.35-1.00%
$20.75B
ROIV
Roivant Sciences Ltd.
$29.03-0.27%
$20.72B